The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Commenced operations in flood-affected Himachal Pradesh
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Robots make it to the healthcare conference panel, reflecting the future potential of technology
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Subscribe To Our Newsletter & Stay Updated
